Engineered erythrocytes eliminate circulating tumor cells and activate macrophage-induced anti-tumor immunity against HCC metastasis
Acta Pharmaceutica Sinica B · 2026-11
DOI: 10.1016/j.apsb.2026.11.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Qinglin Yang und 15 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Province Natural Science Foundation, Taishan Scholar Foundation of Shandong Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- Shandong Province Natural Science Foundation
- Taishan Scholar Foundation of Shandong Province
Zitieren
APA
Yang, Q., Han, L., Wang, J., Li, P., Liu, J., Yuan, S., Wei, S., Xia, Z., Ma, Q., Liu, J., Feng, Y., Yang, X., Zhang, L., Mu, W., Liu, Y., & Zhang, N. (2026). Engineered erythrocytes eliminate circulating tumor cells and activate macrophage-induced anti-tumor immunity against HCC metastasis. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.11.012
Vancouver
Yang Q, Han L, Wang J, Li P, Liu J, Yuan S, et al. Engineered erythrocytes eliminate circulating tumor cells and activate macrophage-induced anti-tumor immunity against HCC metastasis. Acta Pharmaceutica Sinica B. 2026. doi:10.1016/j.apsb.2026.11.012
BibTeX
@article{Yang2026,
author = {Yang, Qinglin and Han, Leiqiang and Wang, Jiarui and Li, Peilong and Liu, Jinhu and Yuan, Shijun and Wei, Suyun and Xia, Zhenxing and Ma, Qingping and Liu, Jie and Feng, Yumeng and Yang, Xinying and Zhang, Le and Mu, Weiwei and Liu, Yongjun and Zhang, Na},
title = {Engineered erythrocytes eliminate circulating tumor cells and activate macrophage-induced anti-tumor immunity against HCC metastasis},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
doi = {10.1016/j.apsb.2026.11.012}
}
EUVIMED